Moreover, it has been also demonstrated that glioma tumorigenesis and malignancy were facilitated by upregulated FOXD2-AS1 through downregulating miR-185-5p and increasing CCND2 expression [10]. This evidence concerns the gene CCND2 and central nervous system cancer.